SDC1 and liver failure: Higher plasma syndecan-1 levels by quartile were also significantly associated with hepatic failure (Fig. 3d, p < 0.001), renal failure (Fig. 3e, p = 0.004), and coagulation failure (Fig. 3f, p = 0.004) at study enrollment as defined by Brussels organ failure scoring.